369 related articles for article (PubMed ID: 34098073)
1. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
[TBL] [Abstract][Full Text] [Related]
2. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.
Lan M; Lu W; Zou T; Li L; Liu F; Cai T; Cai Y
Cell Mol Life Sci; 2021 Mar; 78(5):2105-2129. PubMed ID: 33386887
[TBL] [Abstract][Full Text] [Related]
3. Research progress in nano-drug delivery systems based on the characteristics of the liver cancer microenvironment.
Lu S; Zhang C; Wang J; Zhao L; Li G
Biomed Pharmacother; 2024 Jan; 170():116059. PubMed ID: 38154273
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.
Cao Y; Meng F; Cai T; Gao L; Lee J; Solomevich SO; Aharodnikau UE; Guo T; Lan M; Liu F; Li Q; Viktor T; Li D; Cai Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1950. PubMed ID: 38528388
[TBL] [Abstract][Full Text] [Related]
5. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
[TBL] [Abstract][Full Text] [Related]
6. 3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems.
Brancato V; Gioiella F; Profeta M; Imparato G; Guarnieri D; Urciuolo F; Melone P; Netti PA
Acta Biomater; 2017 Jul; 57():47-58. PubMed ID: 28483691
[TBL] [Abstract][Full Text] [Related]
7. Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside.
Xie F; Wang M; Chen Q; Chi T; Zhu S; Wei P; Yang Y; Zhang L; Li X; Liao Z
Pharmacol Res; 2022 Dec; 186():106522. PubMed ID: 36283629
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy.
Zhang Y; Cai K; Li C; Guo Q; Chen Q; He X; Liu L; Zhang Y; Lu Y; Chen X; Sun T; Huang Y; Cheng J; Jiang C
Nano Lett; 2018 Mar; 18(3):1908-1915. PubMed ID: 29473753
[TBL] [Abstract][Full Text] [Related]
9. Unveiling innovative therapeutic strategies and future trajectories on stimuli-responsive drug delivery systems for targeted treatment of breast carcinoma.
Naser IH; Zaid M; Ali E; Jabar HI; Mustafa AN; Alubiady MHS; Ramadan MF; Muzammil K; Khalaf RM; Jalal SS; Alawadi AH; Alsalamy A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3747-3770. PubMed ID: 38095649
[TBL] [Abstract][Full Text] [Related]
10. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
[TBL] [Abstract][Full Text] [Related]
11. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
12. Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment.
Xiao W; Ruan S; Yu W; Wang R; Hu C; Liu R; Gao H
Mol Pharm; 2017 Oct; 14(10):3489-3498. PubMed ID: 28845990
[TBL] [Abstract][Full Text] [Related]
13. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.
Mi P
Theranostics; 2020; 10(10):4557-4588. PubMed ID: 32292515
[TBL] [Abstract][Full Text] [Related]
15. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
16. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
17. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
18. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
[TBL] [Abstract][Full Text] [Related]
19. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]